Medication info
Minoxidil Tablets 5 mg (Minoxidil)

Minoxidil Tablets 5 mg (Minoxidil)

Prescription medicationTabletOral
Ingredient · strength
Minoxidil›5mg / 1 tablet
Manufacturer / importer
Kunil Biopharm Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 202501605 · Approved 2025.06.27

Summary

Main use
Treatment of resistant hypertension and hypertension with symptoms or target-organ damage
Who takes it
Adults · Children
Adult dose
1. Adults (12 years and older): The initial dose is 5 mg of minoxidil orally once daily. The maintenance dose is 10 - 40 mg daily in 1 - several divided doses. Up to 100 mg may be administered daily. 3. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the reduction in blood pressure. If the reduction in diastolic blood pressure is less than 30 mmHg, the medicine may be administered once daily; if the reduction is 30 mmHg or greater, administer it in 2 divided doses daily. 4. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. 5. Concomitant administration 1) Diuretics: This medicine is administered with a diuretic in patients whose maintenance of salt and water balance depends on renal function. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50 mg per dose twice daily) or another thiazide diuretic (an equivalent effective dose) ② Chlorthalidone (50 - 100 mg per dose once daily) ③ Furosemide (40 mg per dose twice daily) If excessive salt and water retention results in a weight increase of approximately 1.8 kg or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this medicine, administer a β-blocker in divided doses equivalent to 80 - 160 mg of propranolol daily. If β-blockers are contraindicated, methyldopa (250 - 750 mg per dose twice daily) may be given instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. Sympatholytic agents may not completely block the increase in heart rate caused by this medicine, but they can generally prevent tachycardia. Patients receiving a β-blocker before starting treatment with this medicine typically have bradycardia; however, their heart rate is expected to increase to normal with this medicine. When this medicine is administered concomitantly with a β-blocker or other sympatholytic agent, their opposing effects on the heart tend to cancel each other out, resulting in little change in heart rate. Adjust the dose as appropriate according to age and symptoms.
Child dose
2. Children (12 years and younger): The initial dose is 0.2 mg/kg once daily. The dose may be increased by 50 - 100 % until blood pressure is optimally controlled. The maintenance dose is 0.25 mg - 1.0 mg/kg daily. Up to 50 mg may be administered daily.

Ingredients

Manufacturer
Kunil Biopharm Co., Ltd.

Efficacy & effects

Treatment of resistant hypertension and hypertension with symptoms or target-organ damage

  • Hypertension
  • resistant hypertension
View approved original text

This medication is used for the treatment of hypertension occurring due to symptomatic or specific organ damage, and in resistant hypertension that does not respond to treatment with diuretics and two antihypertensives.

How to take

Adult dose

1. Adults (12 years and older): The initial dose is 5 mg of minoxidil orally once daily. The maintenance dose is 10 - 40 mg daily in 1 - several divided doses. Up to 100 mg may be administered daily. 3. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the reduction in blood pressure. If the reduction in diastolic blood pressure is less than 30 mmHg, the medicine may be administered once daily; if the reduction is 30 mmHg or greater, administer it in 2 divided doses daily. 4. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. 5. Concomitant administration 1) Diuretics: This medicine is administered with a diuretic in patients whose maintenance of salt and water balance depends on renal function. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50 mg per dose twice daily) or another thiazide diuretic (an equivalent effective dose) ② Chlorthalidone (50 - 100 mg per dose once daily) ③ Furosemide (40 mg per dose twice daily) If excessive salt and water retention results in a weight increase of approximately 1.8 kg or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this medicine, administer a β-blocker in divided doses equivalent to 80 - 160 mg of propranolol daily. If β-blockers are contraindicated, methyldopa (250 - 750 mg per dose twice daily) may be given instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. Sympatholytic agents may not completely block the increase in heart rate caused by this medicine, but they can generally prevent tachycardia. Patients receiving a β-blocker before starting treatment with this medicine typically have bradycardia; however, their heart rate is expected to increase to normal with this medicine. When this medicine is administered concomitantly with a β-blocker or other sympatholytic agent, their opposing effects on the heart tend to cancel each other out, resulting in little change in heart rate. Adjust the dose as appropriate according to age and symptoms.

Child dose

2. Children (12 years and younger): The initial dose is 0.2 mg/kg once daily. The dose may be increased by 50 - 100 % until blood pressure is optimally controlled. The maintenance dose is 0.25 mg - 1.0 mg/kg daily. Up to 50 mg may be administered daily.

Precautions

This medication should not be used in patients with certain diseases. For example, it should not be administered to patients with a tumor called pheochromocytoma, as it can lower blood pressure and increase the amount of substances secreted by the tumor. It should also be avoided in patients with pulmonary hypertension due to mitral stenosis, those who have had acute myocardial infarction, and patients with an allergic reaction to this medication. Precautions should be taken when using this drug in cases of chronic congestive heart failure, severe renal impairment, and angina, and careful monitoring should be followed based on the physician's instructions. While taking this medication, hypertrichosis (excessive hair growth or darkening of hair) can occur. These changes typically begin on the face and may spread across the body; stopping the medication will halt new hair growth, but returning to the previous state may take months. Hypertrichosis caused by this medication is not due to increased androgen levels and is different from virilization symptoms. Particularly, children and women should be well-informed about this side effect. Additionally, hypersensitivity reactions such as rashes, vesicles, and severe allergic reactions may occur, so any symptoms should be discussed with healthcare professionals immediately. Blood tests may show decreased platelet or white blood cell counts, and red blood cell levels may also drop during the initial treatment. Liver function related values may change, necessitating regular monitoring. Changes in the heart's electrical signals are often discovered in electrocardiograms, but most of these will naturally resolve with continued treatment and are not considered to indicate significant heart problems. Rarely, pericardial effusion (fluid accumulation around the heart) may occur, with a higher incidence in patients with poor kidney function. In such cases, ultrasound may be used to confirm the condition and further treatment may be necessary. Other side effects like weight gain, swelling in hands and feet, increased heart rate, gastrointestinal disturbances, headaches, and menstrual irregularities may occur infrequently. When using this medication, it is common to administer diuretics to prevent excessive accumulation of salt and water, and frequent monitoring of weight and electrolyte status is necessary. Vasodilation may cause an increase in heart rate; thus, heart medications may sometimes be combined with this drug. Patients with decreased kidney function or those undergoing dialysis will need dosages adjusted, and regular evaluations are essential to prevent worsening kidney function. Patients who have had myocardial infarction should only use this medication once their condition is stabilized, and regular tests such as urinalysis, renal function assessment, ECG, chest X-ray, and echocardiogram are important, especially at the onset of administration. This medication may interact with other medications, so caution is advised particularly when taken with antihypertensives, psychotropic drugs, diuretics, and non-steroidal anti-inflammatory medications. During pregnancy, safety has not been established, so avoidance of use is recommended, and during breastfeeding, it is advisable to either avoid administration or discontinue breastfeeding. There is limited experience with its use in children, especially newborns, so it should be administered with extreme caution. In cases of overdose, severe hypotension may occur, so immediate medical attention should be sought, and specific medications may be used to stabilize blood pressure.

Side effects

Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, mucocutaneous syndrome, thrombocytopenia, leukopenia, hematocrit decrease, hemoglobin decrease, decreased red blood cell count, increased ALP, changes in ECG T-wave direction and amplitude, pericardial effusion, thrombosis, peripheral vascular edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, breast pain, gynecomastia, hemolytic anemia, pulmonary infiltrates, increased antinuclear antibodies, headaches, intermittent claudication, frequent menstruation, nausea, vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius in a cool, dry place. This helps preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.